APSR logo
Asian 
Pacific 
Society of 
Respirology

2017 APSR Congress

Scientific Programme

Saturday 25 November 2017

  • 07:30 - 08:45

    Sponsored Breakfast Session 1: Evolving treatment strategies in COPD: What's on the horizon? Sponsored by Novartis

    Room: Theatrette 1, Exhibition Hall
    • 07:30 - 07:35

      Introduction - objectives

      Speaker: David Price, Singapore
    • 07:35 - 07:55

      Shaping the evolution: Key evidence driving COPD treatment strategies?

      Speaker: Peter Barnes, UK
    • 07:55 - 08:10

      Can we switch treatment? What's the evidence?

      Speaker: Wisia Wedzicha, UK
    • 08:10 - 08:25

      ICS: The right patient at the right time

      Speaker: David Price, Singapore
    • 08:25 - 08:30

      Summary and close

      Speaker: David Price, Singapore
    • 08:30 - 08:45

      Chair-led expert discussion and audience Q&A

      Speaker: All speakers
  • Sponsored Breakfast Session 2: Tackling today's challenges in asthma management: Recent updates and advances Sponsored by TEVA

    Room: Theatrette 2, Exhibition Hall
    • 07:30 - 07:40

      Welcome and introduction

      Speaker: Helen Reddel, AU
    • 07:40 - 08:00

      This program currently is under development and is subject to change The right inhaler for the right patient: How much does it matter?

      Speaker: Peter Wark, AU
    • 08:00 - 08:20

      Unravelling the underlying pathologies of severe asthma

      Speaker: Fan Chung, UK
    • 08:20 - 08:45

      Q&A

      Speaker: All speakers
  • 09:00 - 10:30

    Clinical Allergy Immunology: The changing face of allergy

    Room: Cockle Bay 1
    • 09:00 - 09:30

      Environmental effects on immunity and atopy/asthma risk: Lessons from Amish and Hutterite farm children

      Speaker: Anne Sperling, US
    • 09:30 - 10:00

      Emerging role of allergen components in food allergy diagnosis

      Speaker: Leung Ting Fan, Hong Kong
    • 10:00 - 10:30

      Novel immunotherapy for allergy

      Speaker: Jo Douglass, AU
  • Clinical Respiratory Medicine / Environmental and Occupational Health: The lung in a challenging environment

    Room: Cockle Bay 2
    • 09:00 - 09:30

      ET: The lung in microgravity and space

      Speaker: Kim Prisk, US
    • 09:30 - 10:00

      Supersize me; the effect of morbid obesity on lung function

      Speaker: Norbert Berend, AU
    • 10:00 - 10:30

      Lungs on a plane: Travel risk assessment in patients with cardiorespiratory disease

      Speaker: Leigh Seccombe, AU
  • Lung Cancer 2: New approaches in lung cancer

    Room: Darling Harbour Theatre
    • 09:00 - 09:30

      Sorting the Update on CT Screening; monitoring of SPNs and GGOs

      Speaker: Fraser Brims, AU
    • 09:30 - 10:00

      Can sublobar resection be done as a radical resection for small-sized non-small cell lung cancer?: A JCOG strategy

      Speaker: Hisao Asamura, Japan
    • 10:00 - 10:30

      Monitoring patients after curative lung cancer treatments: Current guidelines and newer evidence

      Speaker: Emily Stone, AU
  • Oral Presentations: Clinical Respiratory Medicine 2

    Room: E3.1
    • 09:00 - 09:10

      Non-Invasive Ventilation in Motor Neurone Disease/Amyotrophic Lateral Sclerosis: An Australasian Perspective

      Speaker: Wai Kuen Chow, NSW
    • 09:10 - 09:20

      Clinical Investigation for the Efficacy of Pulse Oxi-Capnometer "Capno-Eye" in Respiratory Failure Patients-Comparison between PACO2, PVCO2, PTCCO2 and ETCO2

      Speaker: Shota Fujimoto, Japan
    • 09:20 - 09:30

      Obesity is an Independent Risk Factor for Obstructive Sleep Apnea in Children

      Speaker: Tingting Xu, China
    • 09:30 - 09:40

      Clinical Course and Outcome of Immunoglobulin G4 Related Lung Disease

      Speaker: Shinhee Park, South Korea
    • 09:40 - 09:50

      Simple Pleural Manometry using Existing Pleural Drainage System: Experience of Two Cases of Pleural Effusions with Post-Drainage Unexpandable Lung and Pneumothorax Ex Vacuo

      Speaker: Geak Poh Tan, Singapore
    • 09:50 - 10:00

      Relationship of Pleural Fluid Ph and Glucose: A Multi-Centre Study of 2971 Cases

      Speaker: Deirdre Fitzgerald, WA
    • 10:00 - 10:10

      Assessment of US Electronic Medical Records to Guide Feasibility and Design of the Novelty Study

      Speaker: Helen Reddel, AU
    • 10:10 - 10:25

      Baseline predictors of non-invasive ventilation use in amyotrophic lateral

      Speaker: Jason Ackrivo, US
  • Oral Presentations: COPD 3

    Room: E3.4
    • 09:00 - 09:30

      Extra-pulmonary morbidities and COPD exacerbations

      Speaker: Shigeo Muro, Japan
    • 09:30 - 09:40

      The Prevalence of COPD in England: An Ontological Approach to Case Detection in

      Primary Care

      Speaker: Louise Rayner, AU
    • 09:40 - 09:50

      Feasibility Analysis of Nebulized Budesonide used for COPD Exacerbations Initial Treatment: A Post Hoc Analysis of a Non-Interventional, Retrospective, Observational Study

      Speaker: Jinping Zheng, China
    • 09:50 - 10:00

      Estimating the Number of Patients Needed to Treat (NNT) with Indacaterol/Glycopyrronium to Prevent COPD Exacerbations: Results from the Flame Study

      Speaker: Jadwiga A Wedzicha, UK
    • 10:00 - 10:10

      Once-Daily Inhaled Umeclidinium/Vilanterol Combination Therapy Compared with Placebo on Exacerbations in Chinese Patients with COPD

      Speaker: Jinping Zheng, China
    • 10:10 - 10:20

      Effect of Erdosteine on the Rate of COPD Exacerbations In Spirometrically Defined Gold II Patients

      Speaker: Peter Calverley, UK
  • Oral Presentations: Interstitial Lung Disease 1

    Room: E3.10
    • 09:00 - 09:10

      Distribution of Honeycombing Area using Quantitative CT Analysis Effects the Mortality in IPF

      Speaker: Hiroaki Nakagawa, Japan
    • 09:10 - 09:20

      Antifibrotic Drug Target Protein (RXFP1) is Expressed in Idiopathic Pulmonary Fibrosis Lungs

      Speaker: Simon Royce, AU
    • 09:20 - 09:30

      Bleomycin-Induced Lung Epithelial Cell Injury is Associated with G2/M Cell Cycle Arrest via Schlafen Axis

      Speaker: Soojin Jang, South Korea
    • 09:30 - 09:40

      Idiopathic Pulmonary Fibrosis in Never Smokers

      Speaker: Daisuke Akahori, Japan
    • 09:40 - 09:50

      Japanese First Guideline for the Treatment of Idiopathic Pulmonary Fibrosis 2017

      Speaker: Sakae Homma, Japan
    • 09:50 - 10:00

      Eligibility for Anti-Fibrotic Treatment in Idiopathic Pulmonary Fibrosis (IPF) Depends on the Predictive Equation used in Pulmonary Function Testing

      Speaker: Ken Goon, AU
    • 10:00 - 10:10

      Long-Term Nintedanib Treatment In Idiopathic Pulmonary Fibrosis (IPF)

      Speaker: Jin Woo Song, South Korea
    • 10:10 - 10:20

      Acute Exacerbation of Idiopathic Pulmonary Fibrosis by New Definition: Incidence, Risk Factors and Outcome

      Speaker: Jehun Kim, South Korea
    • 10:20 - 10:30

      Association of serum KL-6 and CA15-3 levels and connective tissue disease-related interstitial pneumonia (CTD-ILD)

      Speaker: Zijun Guo, China
  • Oral Presentations: Respiratory Infections (Non-TB) 3

    Room: E3.1
    • 09:00 - 09:25

      Management of pneumonia-related sepsis in the community hospital setting

      Speaker: John Studdard, USA
    • 09:25 - 09:35

      Analysis of Mutation Associated with Macrolide Resistance in Bordetella Pertussis in Okinawa, Japan

      Speaker: Saifun Nahar, Japan
    • 09:35 - 09:45

      Macrolides Protect Against Pseudomonas Aeruginosa Infection via Inhibition of Inflammasomes

      Speaker: Jin-Fu Xu, China
    • 09:45 - 09:55

      The Impact of Cigarette Smoke Exposure on Lung Fibroblastic Response after Influenza Pneumonia

      Speaker: Seiwon Lee, South Korea
    • 09:55 - 10:05

      Change in Lung Function in Never-Smokers with Non-Tuberculous Mycobacterial Lung Disease

      Speaker: Takehiko Kobayashi, Japan
  • 10:30 - 11:00

    Morning Tea and Exhibition Viewing

  • 11:00 - 12:00

    Plenary: Presidential Lecture

    Room: Darling Harbour Theatre
    • 11:00 - 11:20

      Lung cancer in 2017

      Speaker: Kwun Fong, AU
    • 11:20 - 11:40

      Seeing is believing - novel imaging techniques for understanding lung diseases

      Speaker: Jane Bourke, AU
    • 11:40 - 12:00

      An end game for tobacco

      Speaker: Matthew Peters, AU
  • 12:00 - 13:15

    Lunch and Exhibition Viewing

    Room: Exhibition Hall
  • Sponsored Lunchtime Session 1: Treating small airways: A step further in asthma and COPD management Sponsored by Chiesi-Emerge Health

    Room: Theatrette 1, Exhibition Hall
    • 12:00 - 12:20

      Asthma and COPD: What is the connection with small airways?

      Speaker: Christine Jenkins, AU
    • 12:20 - 13:00

      Improving outcomes in asthma and COPD with an extra-fine ICS+LABA combination

      Speaker: Alberto Papi, Italy
    • 13:00 - 13:15

      Closing

  • Sponsored Lunchtime Session 2: Respiratory medical evidence: The ins and outs of validity Sponsored by GSK

    Room: Theatrette 2, Exhibition Hall
    • 12:00 - 12:05

      Introduction

      Speaker: Peter Gibson, AU
    • 12:05 - 12:30

      Real life research and its relevance to respiratory medicine

      Speaker: Helen Reddel, AU
    • 12:30 - 13:00

      Effectiveness in everyday practice: The Salford lung study

      Speaker: David Leather, UK
    • 13:00 - 13:15

      Panel discussion and Q&A

      Speaker: All speakers
  • 13:15 - 14:45

    Clinical Respiratory Medicine 1: Breathlessness

    Room: Darling Harbour Theatre
    • 13:15 - 13:30

      A teachable construct for the evaluation of the breathless patient

      Speaker: Matthew Peters, AU
    • 13:30 - 13:55

      CPET in the evaluation of breathlessness

      Speaker: Adrian Chan, Singapore
    • 13:55 - 14:20

      Pharmacological management of breathlessness in established chronic lung disease

      Speaker: Darcy Marciniuk, Canada
    • 14:20 - 14:45

      Pulmonary rehabilitation in chronic lung disease

      Speaker: Anne Holland, AU
  • Respiratory Infections (Non-TB) 1: Bronchiectasis

    Room: Cockle Bay 2
    • 13:15 - 13:45

      Bronchiectasis in asthma and COPD

      Speaker: Jinfu Xu, China
    • 13:45 - 14:15

      Paediatric bronchiectasis in indigenous populations

      Speaker: Anne Chang, AU
    • 14:15 - 14:45

      Management of NTM Infections

      Speaker: Rachel Thomson, AU
  • Respiratory Neurobiology and Sleep 2: Management and consequences of sleep apnea

    Room: Cockle Bay 1
    • 13:15 - 13:45

      Associations between OSA and obesity before and following CPAP treatment or sleep duration

      Speaker: Kazuo Chin, Japan
    • 13:45 - 14:15

      An ambulatory approach versus hospital based approach in managing patients with suspected OSA

      Speaker: David Hui, Hong Kong
    • 14:15 - 14:45

      Understanding upper airway anatomy in OSA - can we predict response to oral appliances?

      Speaker: Peter Cistulli, AU
  • Oral Presentations: Clinical Allergy and Immunology / Paediatric

    Room: E3.4
    • 13:15 - 13:25

      Childhood Asthma Development in Relation with Perinatal and Environmental Factors

      Speaker: Taehoon Lee, South Korea
    • 13:25 - 13:35

      The Application of sIgE/sIgG4 and IFN-Y in Infantile Allergy March

      Speaker: Jiaying Luo, China
    • 13:35 - 13:45

      Peanut Sensitivity and Allergic Rhinitis at 6 Years of Age are Associated with Increased Symptoms of Attention Deficit Hyperactivity Disorder and Oppositional Defiant Disorder Later in Life

      Speaker: Ho-chang Kuo, Taiwan
    • 13:45 - 13:55

      Critical Evaluation of Scientific Content in Pediatric Respiratory Guidelines in China

      Speaker: Jiang Mei, China
    • 13:55 - 14:05

      Development of an In-Vitro Mucus Model to Evaluate the Effect of Magnesium on Current Mucolytic Therapies for Cystic Fibrosis Treatment

      Speaker: Mariam Mamlouk, AU
    • 14:05 - 14:15

      Allergen Immunotherapy Might Reduce Basophil Response in House Dust Mite Allergic Patients

      Speaker: Mulin Feng, China
    • 14:15 - 14:25

      Blood Levels Of Group 2 Innate Lymphoid Cells In Children With Acute Wheeze

      Speaker: Aayushi Sen, UK
  • Oral Presentations: Environmental and Occupational Health and Epidemiology

    Room: E3.10
    • 16:15 - 16:25

      Factors Associated with Pneumococcal Vaccination among the Elderly at Elderly Clubs in Miyakonojo City, Miyazaki Prefecture, Japan

      Speaker: Akihiro Sakamoto, Japan
    • 16:25 - 16:35

      Smoking Behaviour Among Metro North Hospital and Health Services Employees

      Speaker: Mridula Mokoonlall, AU
    • 16:35 - 16:45

      Vaping Knowledge, Attitude and Practice Amongst General Public in Malaysia

      Speaker: Ahmad Izuanuddin Ismail, Malaysia
    • 16:45 - 16:55

      Occupational Exposure to Solvents and Metals and Fixed Airflow Obstruction in Women

      Speaker: Sheikh Alif, AU
    • 16:55 - 17:05

      Lung Function and Long-Term Exposure to PM10 And NO2 In A COPD Cohort

      Speaker: Woo-Jin Kim, South Korea
    • 17:05 - 17:15

      Elevated Expression of MIR-691,MIR-181A,MIR-146A and MIR-21 Involved in Regulating TH1/TH2 Balance with Acute Exposure of Fine Particulate Matter in Mice

      Speaker: Tian-Fang Hou, China
    • 17:15 - 17:25

      Comparison of Asbestos Fiber Detection Methods in Bal Fluid and Lung Tissue of Rat

      Speaker: Mirae Jang, South Korea
    • 17:25 - 17:35

      Circular RNA Mediates Silica-Induced Macrophage Activation via HECTD1 Dependent Ubiquitination

      Speaker: Zewei Zhou, China
  • Poster Session

    Room: Exhibition Hall
  • 14:45 - 15:15

    Afternoon Tea and Exhibition Viewing

  • 18:30 - 19:00

    Pre-Dinner Drinks

    Room: Ballroom Foyer
  • 19:00 - 23:55

    Gala Dinner

    Room: Grand Ballroom